Abstract Background Despite initial response in adjuvant chemotherapy. ovarian cancer patients treated with the combination of paclitaxel and carboplatin frequently suffer from recurrence after few cycles of treatment. and the underlying mechanisms causing the chemoresistance remain unclear. Recently. https://www.ealisboa.com/mega-price-Chili-Rasbora-amazing-save/